Good Sunday morning to all Finom Group subscribers! This week’s research reporting is delivered to subscribers with an emphasis on monthly retail sales and the general dynamics surrounding our neutral risk rating for the S&P 500 (SPX) in September. S&P 500 Expected Move & Lacking Moves of 1% As depicted in the chart above, the S&P 500 made gains each…
Yield Curve Rhetoric: Mounting Fear?
A financial market resource for the every-day investor and trader.
-
Inflation Boogeyman and Bottoming Markets
Seth Golden, , Research Reports, 0
Markets rallied again this past week, but finished on a high note unlike the previous week’s rally. The S&P...
-
Goldman Sachs: Bullish Through Nvidia and September Op/Ex
Seth Golden, , Research Reports, 0
Goldman Sachs Weekly Market Mashup Goldman Sachs’ Scott Rubner Nvidia Outlook
-
Fitbit Retrenches: The Bottoming Phase For A Hardware Company
Seth Golden, , Research Reports, 0
“You want the truth; you can’t handle the truth”! I have been covering Fitbit (FIT) since January of 2016....
-
Markets Are About To Become A Noisy Place
Seth Golden, , Research Reports, 0
One could make the argument that this is one of the more predictable market pullbacks in recent memory. The...
-
Will Markets Give Investors Another Dip to Buy?
Seth Golden, , Research Reports, 0
Over the last 2-3 weeks, Finom Group has outlined our market outlook during the bear market saga, by forecasting...
-
Staying The Course Through The Chop & Slop
Seth Golden, , Research Reports, 1
Who could have predicted 🔮 this past Friday’s intraday price action and how the day ultimately concluded? Well, calling...
-
Lows Are “Possibly” In…
Seth Golden, , Research Reports, 0
There is still considerable debate about whether the bear market has yet set its low. Certainly, if the U.S....
-
Fitbit’ Q1 2017 Results Highlight Inventory And Average Selling Price Reductions
Seth Golden, , Research Reports, 0
Fitbit (FIT) reported rather dismal Q1 2017 metrics last week, but even so shares of FIT rose sharply. Why...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00